BAX · Baxter International Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-02 | Wallace Steven P. |
President, Adv. Surgery |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025. |
Common Stock, $1 par value
|
153 |
| 2026-06-02 | Teaff James |
President, CCS |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2026, from the settlement of vested restricted stock units granted on June 2, 2025. Total includes shares held in the Baxter's Employee Stock Plan. |
Common Stock, $1 par value
|
321 |
| 2026-06-01 | Zielinski Anita A |
SVP & CAO |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
In connection with Ms. Zielinski's appointment to Interim CFO and commensurate with related additional duties, she received a one-time special grant award of restricted stock units which are scheduled to vest on the third anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. Second Amended and Restated 2021 Incentive Plan. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
13,426 |
| 2026-05-05 | Craig Jeffrey A |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
12,836 |
| 2026-05-05 | Wendell Amy McBride |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
12,836 |
| 2026-05-05 | SCHLICHTING NANCY M |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
12,836 |
| 2026-05-05 | Ampofo William A. II |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
12,836 |
| 2026-05-05 | MORRISON PATRICIA |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
12,836 |
| 2026-05-05 | Shafer David Brent |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
12,836 |
| 2026-05-05 | Wilkes David S. |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
12,836 |
| 2026-05-05 | MCDONNELL MICHAEL R |
EVP and CFO |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. |
Common Stock, $1 par value
|
12,836 |
| 2026-03-06 | Zielinski Anita A |
SVP & CAO |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2025. |
Common Stock, $1 par value
|
1,932 |
| 2026-03-06 | Soriano Maria Cecilia |
Group Pres., ITT & Pharma. |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. |
Common Stock, $1 par value
|
2,848 |
| 2026-03-06 | Grade Joel T. |
EVP, Corporate Development |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. |
Common Stock, $1 par value
|
8,153 |
| 2026-03-06 | Rosenbloom David S. |
EVP and General Counsel |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. |
Common Stock, $1 par value
|
6,620 |
| 2026-03-06 | Rasul Reazur |
EVP,Group Pres,Healthcare |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 6, 2026 from the settlement of vested restricted stock units granted on March 6, 2024 and March 6, 2025. |
Common Stock, $1 par value
|
12,674 |
| 2026-03-02 | Rasul Reazur |
EVP,Group Pres,Healthcare |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. |
Common Stock, $1 par value
|
1,614 |
| 2026-03-02 | Rosenbloom David S. |
EVP and General Counsel |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. |
Common Stock, $1 par value
|
1,336 |
| 2026-03-02 | Soriano Maria Cecilia |
Group Pres., ITT & Pharma. |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. |
Common Stock, $1 par value
|
1,852 |
| 2026-02-27 | Carlisle Cynthia |
Executive Vice President, CHRO |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of 11,871 restricted stock units all of which are scheduled to vest on February 27, 2029, subject to satisfaction of the related vesting requirements set forth in the Plan. |
Common Stock, $1 par value
|
11,871 |
| 2026-02-27 | Rosenbloom David S. |
EVP and General Counsel |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
64,655 |
| 2026-02-27 | Hider Andrew P. |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan. |
Common Stock, $1 par value
|
201,804 |
| 2026-02-27 | Zielinski Anita A |
SVP & CAO |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
30,864 |
| 2026-02-27 | Soriano Maria Cecilia |
Group Pres., ITT & Pharma. |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. |
Common Stock, $1 par value
|
23,742 |
| 2026-02-27 | Carlisle Cynthia |
Executive Vice President, CHRO |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan (the "Plan"). |
Common Stock, $1 par value
|
17,806 |
| 2026-02-27 | Soriano Maria Cecilia |
Group Pres., ITT & Pharma. |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
57,471 |
| 2026-02-27 | Grade Joel T. |
EVP, Corporate Development |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. Total includes shares held in the Baxter's Employee Stock Plan. |
Common Stock, $1 par value
|
42,735 |
| 2026-02-27 | Grade Joel T. |
EVP, Corporate Development |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
103,448 |
| 2026-02-27 | Hider Andrew P. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
488,506 |
| 2026-02-27 | Carlisle Cynthia |
Executive Vice President, CHRO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date. |
Stock Option (Right to Buy)
|
43,103 |
| 2026-02-27 | Rosenbloom David S. |
EVP and General Counsel |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. |
Common Stock, $1 par value
|
26,709 |
| 2026-02-13 | MCDONNELL MICHAEL R |
EVP and CFO |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant. |
Common Stock, $1 par value
|
1,811 |
| 2026-02-09 | Rasul Reazur |
EVP,Group Pres,Healthcare |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
5,770 |
| 2026-02-09 | Soriano Maria Cecilia |
Group Pres., ITT & Pharma. |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. |
Common Stock, $1 par value
|
2,273 |
| 2026-02-09 | Grade Joel T. |
EVP, Corporate Development |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan. |
Common Stock, $1 par value
|
9,144 |
| 2026-02-09 | Soriano Maria Cecilia |
Group Pres., ITT & Pharma. |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
918 |
| 2026-02-09 | Rosenbloom David S. |
EVP and General Counsel |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. |
Common Stock, $1 par value
|
17,055 |
| 2026-02-09 | Rosenbloom David S. |
EVP and General Counsel |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
5,225 |
| 2026-02-09 | Rasul Reazur |
EVP,Group Pres,Healthcare |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. |
Common Stock, $1 par value
|
18,951 |
| 2026-02-09 | Grade Joel T. |
EVP, Corporate Development |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. |
Common Stock, $1 par value
|
30,504 |
| 2025-12-12 | Mason Jeanne K |
EVP, Chief HR Officer |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of accelerated Federal Insurance Contributions Act (FICA) taxes for restricted stock unit awards previously granted under Baxter International Inc.'s Long-Term Incentive Plan. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
650 |
| 2025-12-01 | Grade Joel T. |
EVP, Corporate Development |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on December 1, 2025 from the settlement of vested restricted stock units granted on December 1, 2023. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
8,288 |
| 2025-09-02 | Hider Andrew P. |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received RSUs as a pro rata grant under Baxter's 2025 annual equity incentive compensation program that are scheduled to vest in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Plan. |
Common Stock, $1 par value
|
131,813 |
| 2025-09-02 | Borzi James W |
EVP,Chief Supply Chain Officer |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2025 from the settlement of vested restricted stock units granted on September 1, 2023. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
1,848 |
| 2025-09-02 | Hider Andrew P. |
Director |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units (RSUs) as compensation for the unvested portion of certain equity awards previously granted by the reporting person's prior employer (the Make Whole Award). The Make Whole Award is scheduled to vest in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. (Baxter) 2021 Amended and Restated Incentive Plan (the Plan). Any outstanding and unvested portion of the Make Whole Award will immediately vest if the reporting person's employment is terminated by Baxter other than for Cause (as defined in Baxter's Executive Severance Plan) or by the reporting person for Good Reason (as defined in the Offer Letter, effective as of July 7, 2025, by and between the reporting person and Baxter). |
Common Stock, $1 par value
|
236,237 |
| 2025-09-02 | Sonig Alok |
EVP,Group President,Pharma |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on September 2, 2025 from the settlement of vested restricted stock units granted on September 1, 2022 Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
3,191 |
| 2025-09-02 | Grade Joel T. |
EVP, Corporate Development |
Award↑
Filing footnotes — Common Stock, $1 par value (Direct)
The reporting person received a grant of restricted stock units (RSUs) that are scheduled to vest on September 5, 2028, the first business day following the third anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan (the Plan). The RSUs will immediately vest if the reporting person's employment is terminated without Cause (as defined in the Plan). Total includes the automatic reinvestment of dividends and shares held in the Baxter's Employee Stock Plan. |
Common Stock, $1 par value
|
102,712 |
| 2025-09-02 | Hider Andrew P. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The reporting person received stock options as a pro rata grant under Baxter's 2025 annual equity incentive compensation program, with such options becoming exercisable in three equal annual installments beginning on September 2, 2026, the first anniversary of the grant date, subject to the terms of the Plan. |
Stock Option (Right to Buy)
|
465,651 |
| 2025-08-19 | Shafer David Brent |
Director |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on August 19, 2025 from the settlement of vested restricted stock units granted on February 5, 2025, which units vested in accordance with the Amended and Restated Letter Agreement, dated August 2, 2025, by and between Brent Shafer and Baxter International Inc. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
31,337 |
| 2025-06-02 | Rosenbloom David S. |
EVP and General Counsel |
Tax↓
Filing footnotes — Common Stock, $1 par value (Direct)
Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on June 2, 2025 from the settlement of vested restricted stock units granted on June 1, 2022. Total includes the automatic reinvestment of dividends. |
Common Stock, $1 par value
|
16,548 |